High-Yield Expression Of Complex Proteins From Stable Pools Generated By MaxCyte® Electroporation
Source: MaxCyte, Inc.

Researchers created apoptosis-resistant CHO cell lines (DKO1 and DKO2) with the goal of enhancing biotherapeutic production. These Bax/Bak double knockout CHO cells were used to create bulk pools expressing complex biologics with peak titers exceeding 8 g/L. The bulk pool generation process utilized MaxCyte® electroporation for the high-efficiency, high-viability transfection of custom CHO cells, enabling high-density, extended-duration production cultures. These high-viability cultures can deliver cost savings
        access the Application Note!
        
            Log In
        
    
    
    
    Get unlimited access to:
            Trend and Thought Leadership Articles
             
        
        
            Case Studies & White Papers
             
        
        
            Extensive Product Database
             
        
        
            Members-Only Premium Content
             
        
    
        Welcome Back! Please Log In to Continue.
        
            X
        
    
    Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
        Subscribe to Cell & Gene
        X
    
    
        Subscribe to Cell & Gene
    
    